Please provide your email address to receive an email when new articles are posted on . Transcatheter mitral valve repair improved clinical outcomes in patients with HF across all quartiles of mitral ...

A new, retrospective study trying to tease out the benefits of MitraClip procedures according to the etiology of mitral regurgitation (MR) hints that, compared with conservative management, ...

CHICAGO -- Emerging real-world data supported benefits of MitraClip therapy in patients with secondary mitral regurgitation (MR) who didn't fit the COAPT profile, the EXPAND study showed. MR was often ...

CHICAGO, IL—An analysis of patients treated with the MitraClip since its US approval in 2013 suggests that certain subtypes of both degenerative and functional mitral regurgitation (MR) may be ...

January 6, 2012 (London, United Kingdom) — Results from the high-surgical-risk arm of the EVEREST II trial with the percutaneous MitraClip (Abbott) device, suggesting reduced mitral regurgitation and ...

Patients with secondary mitral regurgitation (MR) who were left with high gradients after a MitraClip procedure were not inherently at a disadvantage in their subsequent clinical outcomes, according ...

The MitraClip device yielded low rates of in-hospital mortality rates and procedural complications in a cohort of patients in Germany, according to recent findings. The researchers culled data from ...

Global health care major Abbott Laboratories ABT recently presented one-year positive outcomes from the study of the MitraClip system in transcatheter mitral valve repair (TMVR) procedures in the U.S.

Secondary mitral regurgitation (MR) can be a serious complication of heart failure — in a recent study, two-thirds of the people who were taking the maximum recommended doses of drugs for severe forms ...

August 28, 2011 (Paris, France) – The MitraClip (Abbott) percutaneous mitral-valve repair device may provide new hope for heart-failure patients who have otherwise run out of options [1]. A small ...

A seemingly simple but sophisticated clip may usher in a “new era” for patients suffering from a severe and difficult-to-treat complication of heart failure, according to a new study. The device, ...

Abbott Laboratories ABT recently announced favorable results from two distinctly-conducted analyses of the two-year long COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy ...